Testing of four-sample pools offers resource optimization without compromising diagnostic performance of real time reverse transcriptase-PCR assay for COVID-19
Autor: | Bijina J. Mathew, Jogender Yadav, Arti Shrivas, Shashwati Nema, Ranu Tripathi, Anirudh K. Singh, Ritu Pandey, Debasis Biswas, Sarman Singh, Kuldeep Singh, Ashvini Kumar Yadav, Arun Raghuwanshi, Kudsia Ansari, Prem Shankar, Chitra Patankar, Ankur Joshi, Sudheer Gupta, Ram Kumar Nema |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2021 |
Předmět: |
RNA viruses
Viral Diseases Epidemiology Coronaviruses Pooling Prevalence Artificial Gene Amplification and Extension Polymerase Chain Reaction Turnaround time Geographical Locations Medical Conditions Statistics Medicine and Health Sciences Pathology and laboratory medicine Virus Testing Multidisciplinary Medical microbiology Reverse transcription polymerase chain reaction Infectious Diseases COVID-19 Nucleic Acid Testing Viruses RNA Viral Medicine SARS CoV 2 Pathogens Research Article Asia SARS coronavirus Coronavirus disease 2019 (COVID-19) Concordance Sample (material) Science India Biology Real-Time Polymerase Chain Reaction Research and Analysis Methods Microbiology Specimen Handling Extraction techniques Diagnostic Medicine Humans Molecular Biology Techniques Molecular Biology SARS-CoV-2 Organisms Viral pathogens COVID-19 Biology and Life Sciences Covid 19 Reverse Transcriptase-Polymerase Chain Reaction Gold standard (test) RNA extraction Microbial pathogens People and Places |
Zdroj: | PLoS ONE, Vol 16, Iss 5, p e0251891 (2021) PLoS ONE |
ISSN: | 1932-6203 |
Popis: | Quick identification and isolation of SARS-CoV-2 infected individuals is central to managing the COVID-19 pandemic. Real time reverse transcriptase PCR (rRT-PCR) is the gold standard for COVID-19 diagnosis. However, this resource-intensive and relatively lengthy technique is not ideally suited for mass testing. While pooled testing offers substantial savings in cost and time, the size of the optimum pool that offers complete concordance with results of individualized testing remains elusive. To determine the optimum pool size, we first evaluated the utility of pool testing using simulated 5-sample pools with varying proportions of positive and negative samples. We observed that 5-sample pool testing resulted in false negativity rate of 5% when the pools contained one positive sample. We then examined the diagnostic performance of 4-sample pools in the operational setting of a diagnostic laboratory using 500 consecutive samples in 125 pools. With background prevalence of 2.4%, this 4-sample pool testing showed 100% concordance with individualized testing and resulted in 66% and 59% reduction in resource and turnaround time, respectively. Since the negative predictive value of a diagnostic test varies inversely with prevalence, we re-tested the 4-sample pooling strategy using a fresh batch of 500 samples in 125 pools when the prevalence rose to 12.7% and recorded 100% concordance and reduction in cost and turnaround time by 36% and 30%, respectively. These observations led us to conclude that 4-sample pool testing offers the optimal blend of resource optimization and diagnostic performance across difference disease prevalence settings. |
Databáze: | OpenAIRE |
Externí odkaz: |